The Journal of Immunology, Vol 147, Issue 10 3459-3465, Copyright © 1991 by American Association of Immunologists

ARTICLES

Involvement of a metalloprotease in spontaneous and phorbol ester- induced release of natural killer cell-associated Fc gamma RIII (CD16- II)

D Harrison, JH Phillips and LL Lanier
DNAX Research Institute for Molecular and Cellular Biology, Palo Alto, CA 94304.

Two genes encode the CD16 low affinity IgG FcR. CD16-I (Fc gamma RIII- 1) is expressed on PMN as a phosphatidylinositol-glycan anchored glycoprotein. CD16-II (Fc gamma RIII-2) is expressed on NK cells and macrophages as a transmembrane glycoprotein associated with CD3 zeta or Fc epsilon RI-gamma. NK cells spontaneously release soluble CD16-II from the cell surface and this is enhanced by activation with phorbol ester. In this study, we demonstrate that a metalloprotease is involved in the spontaneous and PMA-induced release of CD16-II from NK cells. 1,10-phenanthroline, an inhibitor of Zn(2+)-dependent metalloproteases, efficiently inhibits CD16-II release. 1,7-phenanthroline, an inactive analogue that doesn't chelate Zn2+ or other divalent metal cations, and inhibitors of serine proteases do not affect spontaneous or PMA-induced release of CD16-II. Murine P815 mastocytoma cells transfected with human CD16-II cDNA shed membrane CD16, and 1,10-phenanthroline inhibits this process. P815 transfectants expressing CD16-II molecules with truncated cytoplasmic domains also release soluble receptors, indicating that the cytoplasmic segment of CD16-II is not required for interaction with the protease or the cytoskeleton. By contrast, 1,10- phenanthroline does not inhibit PMA-induced release of CD16-I glycoprotein from PMN, indicating a different mechanism of release for this phosphatidylinositol-glycan anchored molecule. Prior studies have demonstrated that NK cells are activated via the inositol phosphate pathway after engagement of CD16-II by immune complexes or Ig-coated tumor cell targets. A membrane metalloprotease with substrate specificity for CD16-II that is activated by PKC stimulation may provide a mechanism for releasing the immune complex or target from the effector cells and halting signal transduction.

This article has been cited by other articles:

				N. L. Webster, K. Kedzierska, R. Azzam, G. Paukovics, J. Wilson, S. M. Crowe, and A. Jaworowski Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection J. Leukoc. Biol., February 1, 2006; 79(2): 294 - 302. [Abstract] [Full Text] [PDF]

				X. Zhu, K. J. Hamann, N. M. Munoz, N. Rubio, D. Mayer, A. Hernrreiter, and A. R. Leff Intracellular Expression of Fc{gamma}RIII (CD16) and Its Mobilization by Chemoattractants in Human Eosinophils J. Immunol., September 1, 1998; 161(5): 2574 - 2579. [Abstract] [Full Text] [PDF]

				D. Metes, L. K. Ernst, W. H. Chambers, A. Sulica, R. B. Herberman, and P. A. Morel Expression of Functional CD32 Molecules on Human NK Cells Is Determined by an Allelic Polymorphism of the Fcgamma RIIC Gene Blood, April 1, 1998; 91(7): 2369 - 2380. [Abstract] [Full Text] [PDF]